Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition

被引:37
作者
Guri, Amir J.
Hontecillas, Raquel
Bassaganya-Riera, Josep [1 ]
机构
[1] Dept Human Nutr Foods & Exercise, Lab Nutr Immunol & Mol Nutr, Blacksburg, VA 24061 USA
[2] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA
关键词
PPAR; inflammation; adipocyte hypertrophy; obesity; metabolic syndrome;
D O I
10.1016/j.clnu.2006.08.006
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Over recent years, obesity rates and the onset of obesity-induced chronic diseases have risen dramatically. The more we learn about the physiological and morphological changes that occur during obesity, the more it is becoming clear that obesity-related disorders can be traced back to adipocyte hypertrophy and inflammation at white adipose tissue (WAT). To combat this problem, the body has developed a regulatory system specifically designed at mediating the systemic response to obesity, utilizing free fatty acids (FFAs) and their metabolites as nutrient messengers to signal adaptations from peripheral tissues. These messages are predominantly interceded through the peroxisome proliferator-activated receptors (PPARs), a family of ligand-induced transcription factors that serve as a net of lipid sensors throughout the body. Understanding how and why nutrients, nutrient derivatives and metabolites exert their physiological effects are the key goals in the study of molecular nutrition. By learning about the mechanisms and tissue-specific effects of endogenous PPAR ligands and expanding our knowledge of the body's integrated homeostatic system, we will significantly increase our odds of designing safe and effective preventive and therapeutic interventions that keep us one step ahead of obesity-related diseases. (c) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:871 / 885
页数:15
相关论文
共 118 条
[1]   Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells [J].
Abbot, EL ;
McCormack, JG ;
Reynet, C ;
Hassall, DG ;
Buchan, KW ;
Yeaman, SJ .
FEBS JOURNAL, 2005, 272 (12) :3004-3014
[2]   Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes [J].
Ajuwon, KM ;
Spurlock, ME .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 288 (05) :R1220-R1225
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]  
[Anonymous], HLTH AFF MILLWOOD S
[6]   Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice [J].
Babaev, VR ;
Yancey, PG ;
Ryzhov, SV ;
Kon, V ;
Breyer, MD ;
Magnuson, MA ;
Fazio, S ;
Linton, MF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1647-1653
[7]  
BANNER CD, 1993, J LIPID RES, V34, P1583
[8]   PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[9]   Peroxisome Proliferator-Activated Receptors: The Nutritionally Controlled Molecular Networks that Integrate Inflammation, Immunity and Metabolism [J].
Bassaganya-Riera, Josep ;
Guri, Amir ;
King, Jennifer ;
Hontecillas, Raquel .
CURRENT NUTRITION & FOOD SCIENCE, 2005, 1 (02) :179-187
[10]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953